2014's Better Biotech Buy: Biogen Idec, Inc. vs. Amgen, Inc.

Biotech stocks have had a great run-up over the past year, but it's the biggest names in this sector that are providing investors with a double dose of reliability and growth. Big biotech stocks like Biogen Idec (NASDAQ: BIIB  ) and Amgen (NASDAQ: AMGN  ) have thrived behind blockbuster drugs, and both companies reported earnings for the past quarter this week.

Amgen's recent earnings report didn't surprise many investors used to stellar quarters from this company, as its net profit for the fourth quarter climbed 30% year over year. Meanwhile, Biogen's profits also roared higher in its most recent quarter, fueled by both veteran blockbuster drugs and ballyhooed new therapies the company's hoping will emerge as the blockbusters of the future.

But which company came out on top this earnings season? In the video below, Motley Fool contributor Dan Carroll compares Biogen and Amgen's recent results and talks about how the two stocks stack up for investors going into the rest of 2014.

The new biotech boom poised to reap big profits
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In the Motley Fool's brand-new FREE report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2818257, ~/Articles/ArticleHandler.aspx, 8/31/2015 8:03:23 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Dan Carroll

Dan began writing for the Motley Fool in 2012. He is a health care specialist who also follows the defense industry along with tracking the broader U.S. and international markets.

Today's Market

updated Moments ago Sponsored by:
DOW 16,528.03 -114.98 -0.69%
S&P 500 1,972.18 -16.69 -0.84%
NASD 4,776.51 -51.82 -1.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/31/2015 4:00 PM
AMGN $151.78 Down -4.11 -2.64%
Amgen CAPS Rating: ****
BIIB $297.30 Down -6.39 -2.10%
Biogen Idec CAPS Rating: ****
CELG $118.08 Down -5.96 -4.80%
Celgene CAPS Rating: *****
NVS $97.22 Down -1.13 -1.15%
Novartis CAPS Rating: ****